Wednesday August 12, 2026
Section

Accesswire

Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Press Release

Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Company Highlights Significant Regulatory, Clinical and Strategic Progress Across SkinJect® and Teverelix® Programs and

Read Full Story